

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | behavioral response to nicotine (GO:0035095) | 4.67126477 |
| 2 | fucose catabolic process (GO:0019317) | 4.37939116 |
| 3 | L-fucose metabolic process (GO:0042354) | 4.37939116 |
| 4 | L-fucose catabolic process (GO:0042355) | 4.37939116 |
| 5 | DNA double-strand break processing (GO:0000729) | 4.23911950 |
| 6 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 4.07655391 |
| 7 | inositol phosphate dephosphorylation (GO:0046855) | 4.04631479 |
| 8 | phosphorylated carbohydrate dephosphorylation (GO:0046838) | 4.04631479 |
| 9 | indolalkylamine metabolic process (GO:0006586) | 3.86542160 |
| 10 | mannosylation (GO:0097502) | 3.73289782 |
| 11 | inositol phosphate catabolic process (GO:0071545) | 3.71735334 |
| 12 | kynurenine metabolic process (GO:0070189) | 3.66022554 |
| 13 | cellular ketone body metabolic process (GO:0046950) | 3.58650350 |
| 14 | DNA deamination (GO:0045006) | 3.52967886 |
| 15 | motile cilium assembly (GO:0044458) | 3.51416544 |
| 16 | ketone body metabolic process (GO:1902224) | 3.47836702 |
| 17 | regulation of meiosis I (GO:0060631) | 3.45700905 |
| 18 | detection of light stimulus involved in visual perception (GO:0050908) | 3.39615652 |
| 19 | detection of light stimulus involved in sensory perception (GO:0050962) | 3.39615652 |
| 20 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 3.36721878 |
| 21 | retinal cone cell development (GO:0046549) | 3.31933805 |
| 22 | exogenous drug catabolic process (GO:0042738) | 3.31013287 |
| 23 | negative regulation of execution phase of apoptosis (GO:1900118) | 3.30266811 |
| 24 | auditory receptor cell stereocilium organization (GO:0060088) | 3.22246600 |
| 25 | respiratory chain complex IV assembly (GO:0008535) | 3.18616995 |
| 26 | positive regulation of action potential (GO:0045760) | 3.17418452 |
| 27 | protein polyglutamylation (GO:0018095) | 3.17114669 |
| 28 | rRNA catabolic process (GO:0016075) | 3.15919796 |
| 29 | atrial cardiac muscle cell action potential (GO:0086014) | 3.12221437 |
| 30 | indole-containing compound metabolic process (GO:0042430) | 3.08363795 |
| 31 | response to pheromone (GO:0019236) | 3.06715650 |
| 32 | reflex (GO:0060004) | 3.06404534 |
| 33 | endoderm formation (GO:0001706) | 3.02642442 |
| 34 | drug catabolic process (GO:0042737) | 3.02008553 |
| 35 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 3.00738182 |
| 36 | polyol catabolic process (GO:0046174) | 2.99697675 |
| 37 | phenylpropanoid metabolic process (GO:0009698) | 2.98869718 |
| 38 | nucleotide transmembrane transport (GO:1901679) | 2.95308851 |
| 39 | ubiquinone biosynthetic process (GO:0006744) | 2.95118562 |
| 40 | glycerophospholipid catabolic process (GO:0046475) | 2.95094991 |
| 41 | cytidine deamination (GO:0009972) | 2.93791042 |
| 42 | cytidine metabolic process (GO:0046087) | 2.93791042 |
| 43 | cytidine catabolic process (GO:0006216) | 2.93791042 |
| 44 | glycosphingolipid biosynthetic process (GO:0006688) | 2.93173897 |
| 45 | negative regulation of calcium ion transport into cytosol (GO:0010523) | 2.90097270 |
| 46 | tryptophan catabolic process (GO:0006569) | 2.89616355 |
| 47 | indole-containing compound catabolic process (GO:0042436) | 2.89616355 |
| 48 | indolalkylamine catabolic process (GO:0046218) | 2.89616355 |
| 49 | maturation of 5.8S rRNA (GO:0000460) | 2.89524795 |
| 50 | cell morphogenesis involved in neuron differentiation (GO:0048667) | 2.89466130 |
| 51 | S-adenosylmethionine metabolic process (GO:0046500) | 2.87476423 |
| 52 | axoneme assembly (GO:0035082) | 2.84601313 |
| 53 | primary amino compound metabolic process (GO:1901160) | 2.83370560 |
| 54 | platelet dense granule organization (GO:0060155) | 2.83085404 |
| 55 | prenylation (GO:0097354) | 2.82948766 |
| 56 | protein prenylation (GO:0018342) | 2.82948766 |
| 57 | methionine biosynthetic process (GO:0009086) | 2.82930331 |
| 58 | RNA phosphodiester bond hydrolysis, exonucleolytic (GO:0090503) | 2.78976859 |
| 59 | regulation of memory T cell differentiation (GO:0043380) | 2.77779619 |
| 60 | serotonin metabolic process (GO:0042428) | 2.76853620 |
| 61 | neuronal action potential (GO:0019228) | 2.74775826 |
| 62 | regulation of action potential (GO:0098900) | 2.73510158 |
| 63 | pseudouridine synthesis (GO:0001522) | 2.72338189 |
| 64 | attachment of spindle microtubules to kinetochore (GO:0008608) | 2.71022750 |
| 65 | post-embryonic morphogenesis (GO:0009886) | 2.70773334 |
| 66 | flavonoid metabolic process (GO:0009812) | 2.70579143 |
| 67 | ubiquinone metabolic process (GO:0006743) | 2.69905455 |
| 68 | synaptic transmission, cholinergic (GO:0007271) | 2.65744598 |
| 69 | organelle disassembly (GO:1903008) | 2.65432933 |
| 70 | inner ear receptor stereocilium organization (GO:0060122) | 2.64604343 |
| 71 | recombinational repair (GO:0000725) | 2.64169758 |
| 72 | neuronal action potential propagation (GO:0019227) | 2.63913739 |
| 73 | double-strand break repair via homologous recombination (GO:0000724) | 2.63161781 |
| 74 | regulation of nuclear cell cycle DNA replication (GO:0033262) | 2.62721294 |
| 75 | quinone biosynthetic process (GO:1901663) | 2.60915962 |
| 76 | protein-cofactor linkage (GO:0018065) | 2.60794874 |
| 77 | rhodopsin mediated signaling pathway (GO:0016056) | 2.60275806 |
| 78 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 2.57958712 |
| 79 | regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090266) | 2.57400027 |
| 80 | regulation of mitotic spindle checkpoint (GO:1903504) | 2.57400027 |
| 81 | ribonucleoprotein complex disassembly (GO:0032988) | 2.57349964 |
| 82 | male meiosis I (GO:0007141) | 2.57266804 |
| 83 | oxidative demethylation (GO:0070989) | 2.56731073 |
| 84 | tryptophan metabolic process (GO:0006568) | 2.56730151 |
| 85 | regulation of rhodopsin mediated signaling pathway (GO:0022400) | 2.53869153 |
| 86 | aspartate family amino acid biosynthetic process (GO:0009067) | 2.53820146 |
| 87 | positive regulation of meiosis (GO:0045836) | 2.52695137 |
| 88 | negative regulation of telomere maintenance (GO:0032205) | 2.52472453 |
| 89 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 2.47896533 |
| 90 | iron-sulfur cluster assembly (GO:0016226) | 2.47400806 |
| 91 | metallo-sulfur cluster assembly (GO:0031163) | 2.47400806 |
| 92 | negative regulation of heart rate (GO:0010459) | 2.47306233 |
| 93 | preassembly of GPI anchor in ER membrane (GO:0016254) | 2.46159177 |
| 94 | magnesium ion transport (GO:0015693) | 2.46012805 |
| 95 | methionine metabolic process (GO:0006555) | 2.45399160 |
| 96 | cytochrome complex assembly (GO:0017004) | 2.45333514 |
| 97 | DNA catabolic process, exonucleolytic (GO:0000738) | 2.43400228 |
| 98 | water-soluble vitamin biosynthetic process (GO:0042364) | 2.43127819 |
| 99 | imidazole-containing compound metabolic process (GO:0052803) | 2.41661177 |
| 100 | GPI anchor metabolic process (GO:0006505) | 2.40763838 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IGF1R_20145208_ChIP-Seq_DFB_Human | 4.36769704 |
| 2 | ZNF274_21170338_ChIP-Seq_K562_Hela | 3.13931712 |
| 3 | TAF15_26573619_Chip-Seq_HEK293_Human | 3.04612444 |
| 4 | VDR_22108803_ChIP-Seq_LS180_Human | 2.99768088 |
| 5 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.95296563 |
| 6 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.85479058 |
| 7 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 2.83567921 |
| 8 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 2.70629380 |
| 9 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 2.40756300 |
| 10 | EWS_26573619_Chip-Seq_HEK293_Human | 2.34667902 |
| 11 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 2.23077336 |
| 12 | FUS_26573619_Chip-Seq_HEK293_Human | 2.22264399 |
| 13 | P300_19829295_ChIP-Seq_ESCs_Human | 2.15607801 |
| 14 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.13189404 |
| 15 | ER_23166858_ChIP-Seq_MCF-7_Human | 2.10993052 |
| 16 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.06075362 |
| 17 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 2.05963145 |
| 18 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 2.02204250 |
| 19 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 2.00545388 |
| 20 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.92404722 |
| 21 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.75343326 |
| 22 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.74863766 |
| 23 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.67718704 |
| 24 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.64148232 |
| 25 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.61061677 |
| 26 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.60866101 |
| 27 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.60755243 |
| 28 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.60696087 |
| 29 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.60631585 |
| 30 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.57135528 |
| 31 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.56176530 |
| 32 | STAT3_23295773_ChIP-Seq_U87_Human | 1.55749049 |
| 33 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.55235929 |
| 34 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.55184297 |
| 35 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.54869843 |
| 36 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.51356885 |
| 37 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.51356885 |
| 38 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.51188223 |
| 39 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.50832146 |
| 40 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.49051390 |
| 41 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.48255591 |
| 42 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.46391398 |
| 43 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.45754300 |
| 44 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.45754300 |
| 45 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.45299995 |
| 46 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.41358867 |
| 47 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.40010104 |
| 48 | TCF4_23295773_ChIP-Seq_U87_Human | 1.39446476 |
| 49 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.38297854 |
| 50 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.37042662 |
| 51 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.36702042 |
| 52 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.35409505 |
| 53 | AR_25329375_ChIP-Seq_VCAP_Human | 1.34632767 |
| 54 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.34290576 |
| 55 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.33220897 |
| 56 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.32918247 |
| 57 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.32918247 |
| 58 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.31879817 |
| 59 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.31072912 |
| 60 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.28913357 |
| 61 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.28776647 |
| 62 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.27783814 |
| 63 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.26692592 |
| 64 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.25839765 |
| 65 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 1.25819400 |
| 66 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.25162533 |
| 67 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.23517576 |
| 68 | NCOR_22424771_ChIP-Seq_293T_Human | 1.23002692 |
| 69 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.22322464 |
| 70 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.20374908 |
| 71 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.19986159 |
| 72 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 1.19957766 |
| 73 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.18052626 |
| 74 | CEBPA_26348894_ChIP-Seq_LIVER_Mouse | 1.17411667 |
| 75 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.16879226 |
| 76 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 1.16648157 |
| 77 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.16290369 |
| 78 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 1.15041390 |
| 79 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 1.14456691 |
| 80 | HOXB7_26014856_ChIP-Seq_BT474_Human | 1.12399325 |
| 81 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.12192348 |
| 82 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.11150819 |
| 83 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 1.10120273 |
| 84 | AR_20517297_ChIP-Seq_VCAP_Human | 1.05735213 |
| 85 | GATA3_26560356_Chip-Seq_TH2_Human | 1.05716769 |
| 86 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.04681951 |
| 87 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.04426982 |
| 88 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.03973153 |
| 89 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.03464619 |
| 90 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.02543198 |
| 91 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 1.00488334 |
| 92 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.00108334 |
| 93 | JUN_21703547_ChIP-Seq_K562_Human | 0.99670878 |
| 94 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 0.99285116 |
| 95 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 0.99225132 |
| 96 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.96162034 |
| 97 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.96055209 |
| 98 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.96018972 |
| 99 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 0.95906135 |
| 100 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.95854203 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003787_abnormal_imprinting | 3.39521840 |
| 2 | MP0002102_abnormal_ear_morphology | 3.16255497 |
| 3 | MP0006072_abnormal_retinal_apoptosis | 2.98487039 |
| 4 | MP0003646_muscle_fatigue | 2.91827075 |
| 5 | MP0000569_abnormal_digit_pigmentation | 2.59536212 |
| 6 | MP0003195_calcinosis | 2.55939928 |
| 7 | MP0004147_increased_porphyrin_level | 2.54227093 |
| 8 | MP0002138_abnormal_hepatobiliary_system | 2.43873581 |
| 9 | MP0005551_abnormal_eye_electrophysiolog | 2.33875980 |
| 10 | MP0009046_muscle_twitch | 2.29444961 |
| 11 | MP0008057_abnormal_DNA_replication | 2.23051036 |
| 12 | MP0003880_abnormal_central_pattern | 2.19408483 |
| 13 | MP0003890_abnormal_embryonic-extraembry | 2.12354756 |
| 14 | MP0000427_abnormal_hair_cycle | 2.09057383 |
| 15 | MP0008877_abnormal_DNA_methylation | 2.08062630 |
| 16 | MP0001501_abnormal_sleep_pattern | 1.96127549 |
| 17 | MP0003011_delayed_dark_adaptation | 1.95448736 |
| 18 | MP0005645_abnormal_hypothalamus_physiol | 1.91576397 |
| 19 | MP0005253_abnormal_eye_physiology | 1.89295092 |
| 20 | MP0002009_preneoplasia | 1.86551859 |
| 21 | MP0004215_abnormal_myocardial_fiber | 1.84634883 |
| 22 | MP0001485_abnormal_pinna_reflex | 1.79602783 |
| 23 | MP0002876_abnormal_thyroid_physiology | 1.75889939 |
| 24 | MP0002733_abnormal_thermal_nociception | 1.74667903 |
| 25 | MP0004270_analgesia | 1.70911560 |
| 26 | MP0006292_abnormal_olfactory_placode | 1.69663364 |
| 27 | MP0009745_abnormal_behavioral_response | 1.68410515 |
| 28 | MP0004742_abnormal_vestibular_system | 1.68316549 |
| 29 | MP0001486_abnormal_startle_reflex | 1.66563905 |
| 30 | MP0005379_endocrine/exocrine_gland_phen | 1.65650341 |
| 31 | MP0000372_irregular_coat_pigmentation | 1.63239981 |
| 32 | MP0002139_abnormal_hepatobiliary_system | 1.63176490 |
| 33 | MP0001529_abnormal_vocalization | 1.56110387 |
| 34 | MP0008872_abnormal_physiological_respon | 1.54557784 |
| 35 | MP0005646_abnormal_pituitary_gland | 1.54250795 |
| 36 | MP0002837_dystrophic_cardiac_calcinosis | 1.50763034 |
| 37 | MP0005671_abnormal_response_to | 1.50079266 |
| 38 | MP0002735_abnormal_chemical_nociception | 1.49856580 |
| 39 | MP0004133_heterotaxia | 1.47603878 |
| 40 | MP0005386_behavior/neurological_phenoty | 1.47131024 |
| 41 | MP0004924_abnormal_behavior | 1.47131024 |
| 42 | MP0001968_abnormal_touch/_nociception | 1.46061256 |
| 43 | MP0008875_abnormal_xenobiotic_pharmacok | 1.43702402 |
| 44 | MP0003121_genomic_imprinting | 1.42895676 |
| 45 | MP0008058_abnormal_DNA_repair | 1.41164990 |
| 46 | MP0010329_abnormal_lipoprotein_level | 1.36701123 |
| 47 | MP0004043_abnormal_pH_regulation | 1.35313941 |
| 48 | MP0006276_abnormal_autonomic_nervous | 1.34332972 |
| 49 | MP0002272_abnormal_nervous_system | 1.31074504 |
| 50 | MP0003718_maternal_effect | 1.30776314 |
| 51 | MP0008775_abnormal_heart_ventricle | 1.26875427 |
| 52 | MP0001986_abnormal_taste_sensitivity | 1.24636673 |
| 53 | MP0005332_abnormal_amino_acid | 1.23711223 |
| 54 | MP0001970_abnormal_pain_threshold | 1.21431845 |
| 55 | MP0000631_abnormal_neuroendocrine_gland | 1.21321211 |
| 56 | MP0002736_abnormal_nociception_after | 1.16918681 |
| 57 | MP0005167_abnormal_blood-brain_barrier | 1.14516228 |
| 58 | MP0002572_abnormal_emotion/affect_behav | 1.13512414 |
| 59 | MP0003252_abnormal_bile_duct | 1.11012845 |
| 60 | MP0004484_altered_response_of | 1.10719783 |
| 61 | MP0002163_abnormal_gland_morphology | 1.09074436 |
| 62 | MP0009764_decreased_sensitivity_to | 1.08381738 |
| 63 | MP0002160_abnormal_reproductive_system | 1.08326218 |
| 64 | MP0002064_seizures | 1.07904373 |
| 65 | MP0005389_reproductive_system_phenotype | 1.07776483 |
| 66 | MP0004885_abnormal_endolymph | 1.07039492 |
| 67 | MP0009697_abnormal_copulation | 1.04144506 |
| 68 | MP0001764_abnormal_homeostasis | 1.02183764 |
| 69 | MP0005085_abnormal_gallbladder_physiolo | 1.01836542 |
| 70 | MP0001348_abnormal_lacrimal_gland | 0.98548726 |
| 71 | MP0000230_abnormal_systemic_arterial | 0.97091053 |
| 72 | MP0002734_abnormal_mechanical_nocicepti | 0.93680794 |
| 73 | MP0000647_abnormal_sebaceous_gland | 0.91464044 |
| 74 | MP0004085_abnormal_heartbeat | 0.91449663 |
| 75 | MP0002067_abnormal_sensory_capabilities | 0.90884170 |
| 76 | MP0005084_abnormal_gallbladder_morpholo | 0.86642102 |
| 77 | MP0003635_abnormal_synaptic_transmissio | 0.85639567 |
| 78 | MP0002909_abnormal_adrenal_gland | 0.85411929 |
| 79 | MP0005360_urolithiasis | 0.84553297 |
| 80 | MP0005448_abnormal_energy_balance | 0.84474510 |
| 81 | MP0002332_abnormal_exercise_endurance | 0.83169378 |
| 82 | MP0001929_abnormal_gametogenesis | 0.82872601 |
| 83 | MP0001661_extended_life_span | 0.81334504 |
| 84 | MP0002557_abnormal_social/conspecific_i | 0.80712234 |
| 85 | MP0001919_abnormal_reproductive_system | 0.80407198 |
| 86 | MP0005187_abnormal_penis_morphology | 0.80275579 |
| 87 | MP0005266_abnormal_metabolism | 0.79623598 |
| 88 | MP0003137_abnormal_impulse_conducting | 0.79404705 |
| 89 | MP0003879_abnormal_hair_cell | 0.78524215 |
| 90 | MP0001963_abnormal_hearing_physiology | 0.78309712 |
| 91 | MP0001440_abnormal_grooming_behavior | 0.78238902 |
| 92 | MP0000383_abnormal_hair_follicle | 0.76997187 |
| 93 | MP0002693_abnormal_pancreas_physiology | 0.75526947 |
| 94 | MP0004145_abnormal_muscle_electrophysio | 0.73973672 |
| 95 | MP0004142_abnormal_muscle_tone | 0.70844278 |
| 96 | MP0010094_abnormal_chromosome_stability | 0.70266923 |
| 97 | MP0001984_abnormal_olfaction | 0.69915096 |
| 98 | MP0002095_abnormal_skin_pigmentation | 0.69547733 |
| 99 | MP0003937_abnormal_limbs/digits/tail_de | 0.69328533 |
| 100 | MP0005220_abnormal_exocrine_pancreas | 0.68792415 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Type II lissencephaly (HP:0007260) | 4.77379931 |
| 2 | Congenital stationary night blindness (HP:0007642) | 4.19884371 |
| 3 | Pancreatic cysts (HP:0001737) | 4.15718382 |
| 4 | Cerebellar dysplasia (HP:0007033) | 3.83186716 |
| 5 | Methylmalonic acidemia (HP:0002912) | 3.67609423 |
| 6 | True hermaphroditism (HP:0010459) | 3.50736450 |
| 7 | Pancreatic fibrosis (HP:0100732) | 3.39510778 |
| 8 | Abnormality of vitamin B metabolism (HP:0004340) | 3.34183308 |
| 9 | Abnormality of the vitamin B12 metabolism (HP:0004341) | 3.16415520 |
| 10 | Methylmalonic aciduria (HP:0012120) | 3.08837787 |
| 11 | Stomach cancer (HP:0012126) | 2.98459262 |
| 12 | Optic nerve hypoplasia (HP:0000609) | 2.91814785 |
| 13 | Abnormality of the renal cortex (HP:0011035) | 2.88381342 |
| 14 | Hypoplasia of the pons (HP:0012110) | 2.84580305 |
| 15 | Aplasia/Hypoplasia of the optic nerve (HP:0008058) | 2.71749685 |
| 16 | Lissencephaly (HP:0001339) | 2.69656147 |
| 17 | Abnormality of homocysteine metabolism (HP:0010919) | 2.69393043 |
| 18 | Homocystinuria (HP:0002156) | 2.69393043 |
| 19 | Inability to walk (HP:0002540) | 2.69286654 |
| 20 | Absent speech (HP:0001344) | 2.67315637 |
| 21 | Retinal dysplasia (HP:0007973) | 2.64213000 |
| 22 | Abnormality of the pons (HP:0007361) | 2.59864206 |
| 23 | Gaze-evoked nystagmus (HP:0000640) | 2.57028164 |
| 24 | Medial flaring of the eyebrow (HP:0010747) | 2.53006209 |
| 25 | Bile duct proliferation (HP:0001408) | 2.51390784 |
| 26 | Abnormal biliary tract physiology (HP:0012439) | 2.51390784 |
| 27 | Hyperventilation (HP:0002883) | 2.49825660 |
| 28 | Retinal atrophy (HP:0001105) | 2.48650014 |
| 29 | Abnormality of vitamin metabolism (HP:0100508) | 2.46307989 |
| 30 | Volvulus (HP:0002580) | 2.41602546 |
| 31 | Acute necrotizing encephalopathy (HP:0006965) | 2.40462883 |
| 32 | Anterior segment dysgenesis (HP:0007700) | 2.39201747 |
| 33 | Ketoacidosis (HP:0001993) | 2.38681405 |
| 34 | Occipital encephalocele (HP:0002085) | 2.35184262 |
| 35 | Type I transferrin isoform profile (HP:0003642) | 2.32837610 |
| 36 | Nephronophthisis (HP:0000090) | 2.31349037 |
| 37 | Acute encephalopathy (HP:0006846) | 2.30602814 |
| 38 | Congenital sensorineural hearing impairment (HP:0008527) | 2.29434400 |
| 39 | Congenital primary aphakia (HP:0007707) | 2.29369835 |
| 40 | Mitochondrial inheritance (HP:0001427) | 2.26742750 |
| 41 | Gait imbalance (HP:0002141) | 2.23388516 |
| 42 | Increased CSF lactate (HP:0002490) | 2.23304669 |
| 43 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.23133190 |
| 44 | Renal cortical cysts (HP:0000803) | 2.22401651 |
| 45 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.21598068 |
| 46 | Hyperglycinemia (HP:0002154) | 2.21202349 |
| 47 | Abnormality of midbrain morphology (HP:0002418) | 2.21079406 |
| 48 | Molar tooth sign on MRI (HP:0002419) | 2.21079406 |
| 49 | Severe combined immunodeficiency (HP:0004430) | 2.20870953 |
| 50 | Colon cancer (HP:0003003) | 2.20237040 |
| 51 | Abnormality of methionine metabolism (HP:0010901) | 2.19692853 |
| 52 | Hypothermia (HP:0002045) | 2.17193653 |
| 53 | Ketosis (HP:0001946) | 2.17034355 |
| 54 | Abnormality of glycine metabolism (HP:0010895) | 2.16706807 |
| 55 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.16706807 |
| 56 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 2.16233527 |
| 57 | Hyperglycinuria (HP:0003108) | 2.15862779 |
| 58 | Focal motor seizures (HP:0011153) | 2.14120794 |
| 59 | Poor coordination (HP:0002370) | 2.14042209 |
| 60 | Abnormality of the renal medulla (HP:0100957) | 2.07945565 |
| 61 | Keratoconus (HP:0000563) | 2.07214389 |
| 62 | Increased corneal curvature (HP:0100692) | 2.07214389 |
| 63 | Febrile seizures (HP:0002373) | 2.07161463 |
| 64 | Sclerocornea (HP:0000647) | 2.05835080 |
| 65 | Progressive inability to walk (HP:0002505) | 2.04892174 |
| 66 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 2.03542184 |
| 67 | Hypoplasia of the fovea (HP:0007750) | 2.03542184 |
| 68 | Progressive macrocephaly (HP:0004481) | 2.03477363 |
| 69 | Cystic liver disease (HP:0006706) | 2.03408167 |
| 70 | Aplasia/Hypoplasia affecting the fundus (HP:0008057) | 1.99148277 |
| 71 | Proximal tubulopathy (HP:0000114) | 1.99142394 |
| 72 | Genital tract atresia (HP:0001827) | 1.96862436 |
| 73 | Birth length less than 3rd percentile (HP:0003561) | 1.96477063 |
| 74 | Attenuation of retinal blood vessels (HP:0007843) | 1.96399960 |
| 75 | Broad-based gait (HP:0002136) | 1.93454369 |
| 76 | Vaginal atresia (HP:0000148) | 1.92996371 |
| 77 | Intestinal atresia (HP:0011100) | 1.92887475 |
| 78 | Nephrogenic diabetes insipidus (HP:0009806) | 1.90837887 |
| 79 | Severe muscular hypotonia (HP:0006829) | 1.90165804 |
| 80 | Protruding tongue (HP:0010808) | 1.89531912 |
| 81 | Congenital hepatic fibrosis (HP:0002612) | 1.89202311 |
| 82 | Abnormal protein N-linked glycosylation (HP:0012347) | 1.86956742 |
| 83 | Abnormal protein glycosylation (HP:0012346) | 1.86956742 |
| 84 | Abnormal glycosylation (HP:0012345) | 1.86956742 |
| 85 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 1.86956742 |
| 86 | Abnormality of the vitreous humor (HP:0004327) | 1.83893374 |
| 87 | Chronic hepatic failure (HP:0100626) | 1.83868736 |
| 88 | Hepatic necrosis (HP:0002605) | 1.82641020 |
| 89 | Tubular atrophy (HP:0000092) | 1.81038417 |
| 90 | Hepatocellular necrosis (HP:0001404) | 1.79681895 |
| 91 | Male pseudohermaphroditism (HP:0000037) | 1.79286290 |
| 92 | Thyroiditis (HP:0100646) | 1.79051664 |
| 93 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 1.78404191 |
| 94 | Abnormality of alanine metabolism (HP:0010916) | 1.78404191 |
| 95 | Hyperalaninemia (HP:0003348) | 1.78404191 |
| 96 | Abnormality of the fovea (HP:0000493) | 1.78075639 |
| 97 | Short chin (HP:0000331) | 1.78031626 |
| 98 | Aplasia/Hypoplasia of the tongue (HP:0010295) | 1.77907998 |
| 99 | Abnormality of serum amino acid levels (HP:0003112) | 1.77395070 |
| 100 | Concave nail (HP:0001598) | 1.77119088 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FRK | 3.82190019 |
| 2 | ZAK | 3.64562034 |
| 3 | TAOK3 | 3.24455248 |
| 4 | GRK1 | 3.13428572 |
| 5 | ACVR1B | 3.01522231 |
| 6 | TRIM28 | 2.95102282 |
| 7 | MAP4K2 | 2.85332076 |
| 8 | TESK2 | 2.77504890 |
| 9 | ADRBK2 | 2.64389503 |
| 10 | TXK | 2.61350333 |
| 11 | WNK3 | 2.53049987 |
| 12 | MAP3K4 | 2.21920897 |
| 13 | STK16 | 2.16877911 |
| 14 | CASK | 2.09302617 |
| 15 | BMPR1B | 2.05156506 |
| 16 | MAP2K7 | 1.69580485 |
| 17 | SIK2 | 1.68188698 |
| 18 | BCR | 1.62102306 |
| 19 | MST4 | 1.50892388 |
| 20 | TLK1 | 1.50317772 |
| 21 | NUAK1 | 1.49194431 |
| 22 | OXSR1 | 1.46744856 |
| 23 | MAPKAPK3 | 1.46360062 |
| 24 | SIK3 | 1.42748889 |
| 25 | NEK1 | 1.27287398 |
| 26 | ERBB3 | 1.22858130 |
| 27 | DAPK2 | 1.18471647 |
| 28 | KDR | 1.16458220 |
| 29 | PAK3 | 1.16357942 |
| 30 | CAMKK2 | 1.13239310 |
| 31 | MAPK13 | 1.12344865 |
| 32 | STK39 | 1.09668996 |
| 33 | ADRBK1 | 1.09018083 |
| 34 | WNK4 | 1.08050960 |
| 35 | CSNK1G2 | 0.99076274 |
| 36 | GRK7 | 0.97456086 |
| 37 | BRSK2 | 0.97102521 |
| 38 | STK3 | 0.92706404 |
| 39 | PRKCE | 0.91413023 |
| 40 | PINK1 | 0.90421373 |
| 41 | STK38L | 0.90048921 |
| 42 | PLK4 | 0.89138275 |
| 43 | MKNK2 | 0.88460991 |
| 44 | VRK1 | 0.84161278 |
| 45 | PRKCG | 0.83578565 |
| 46 | PIK3CA | 0.83367790 |
| 47 | LATS1 | 0.80917042 |
| 48 | DAPK1 | 0.80160605 |
| 49 | NLK | 0.78692443 |
| 50 | CSNK1G1 | 0.78424458 |
| 51 | CAMK2A | 0.77350998 |
| 52 | TRPM7 | 0.76933415 |
| 53 | ITK | 0.75767824 |
| 54 | PLK2 | 0.75516191 |
| 55 | EIF2AK3 | 0.73542391 |
| 56 | PNCK | 0.72858423 |
| 57 | SRPK1 | 0.72082368 |
| 58 | PTK2B | 0.71743892 |
| 59 | CHEK2 | 0.68734542 |
| 60 | AKT3 | 0.68029473 |
| 61 | MAP3K5 | 0.67319621 |
| 62 | INSRR | 0.66957778 |
| 63 | MELK | 0.65711833 |
| 64 | CSNK1A1L | 0.65037593 |
| 65 | NTRK2 | 0.63968290 |
| 66 | IRAK1 | 0.63682409 |
| 67 | CCNB1 | 0.62082428 |
| 68 | LIMK1 | 0.59780319 |
| 69 | MAP2K6 | 0.59592364 |
| 70 | TGFBR1 | 0.58723908 |
| 71 | STK24 | 0.58491909 |
| 72 | CSNK1G3 | 0.58266689 |
| 73 | CAMK2B | 0.57090529 |
| 74 | MARK1 | 0.56322093 |
| 75 | PLK3 | 0.55219444 |
| 76 | CDK19 | 0.55185467 |
| 77 | PRKCQ | 0.54659576 |
| 78 | MAP2K4 | 0.47604846 |
| 79 | TNIK | 0.42679832 |
| 80 | NEK6 | 0.41812684 |
| 81 | CAMK2D | 0.41803642 |
| 82 | TAF1 | 0.40648604 |
| 83 | SYK | 0.40136784 |
| 84 | PLK1 | 0.39451050 |
| 85 | MINK1 | 0.38342465 |
| 86 | TEC | 0.38154366 |
| 87 | MAPK7 | 0.38018424 |
| 88 | IGF1R | 0.36155885 |
| 89 | CDK3 | 0.35921523 |
| 90 | RPS6KA5 | 0.35740979 |
| 91 | PRKACA | 0.34856104 |
| 92 | CSNK1D | 0.34175900 |
| 93 | IRAK2 | 0.31280253 |
| 94 | BMX | 0.30828892 |
| 95 | PRKCA | 0.30322519 |
| 96 | ROCK1 | 0.30251932 |
| 97 | IKBKE | 0.29297931 |
| 98 | TIE1 | 0.29260339 |
| 99 | MKNK1 | 0.29237051 |
| 100 | ABL1 | 0.27577776 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Phototransduction_Homo sapiens_hsa04744 | 3.47190534 |
| 2 | Selenocompound metabolism_Homo sapiens_hsa00450 | 3.02988607 |
| 3 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 2.76136330 |
| 4 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.43432528 |
| 5 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 2.32566717 |
| 6 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 2.30209791 |
| 7 | Protein export_Homo sapiens_hsa03060 | 2.16570747 |
| 8 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 2.15245577 |
| 9 | Nicotine addiction_Homo sapiens_hsa05033 | 2.11645785 |
| 10 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.04086779 |
| 11 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.98249508 |
| 12 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.96235281 |
| 13 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.90633825 |
| 14 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.90539663 |
| 15 | Retinol metabolism_Homo sapiens_hsa00830 | 1.83555641 |
| 16 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.81945340 |
| 17 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.78762003 |
| 18 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.76869478 |
| 19 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.68935380 |
| 20 | Homologous recombination_Homo sapiens_hsa03440 | 1.61721703 |
| 21 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.60943170 |
| 22 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.59462869 |
| 23 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.58356085 |
| 24 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.57652870 |
| 25 | Olfactory transduction_Homo sapiens_hsa04740 | 1.54214699 |
| 26 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.49591851 |
| 27 | Taste transduction_Homo sapiens_hsa04742 | 1.46147008 |
| 28 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.41702678 |
| 29 | RNA degradation_Homo sapiens_hsa03018 | 1.33056197 |
| 30 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.32998599 |
| 31 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.30327928 |
| 32 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.26005565 |
| 33 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.25663741 |
| 34 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.23639291 |
| 35 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.23634649 |
| 36 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.23592660 |
| 37 | Morphine addiction_Homo sapiens_hsa05032 | 1.21434858 |
| 38 | GABAergic synapse_Homo sapiens_hsa04727 | 1.16092449 |
| 39 | Basal transcription factors_Homo sapiens_hsa03022 | 1.16008519 |
| 40 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.14991050 |
| 41 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.13632815 |
| 42 | Histidine metabolism_Homo sapiens_hsa00340 | 1.13414369 |
| 43 | Peroxisome_Homo sapiens_hsa04146 | 1.09593251 |
| 44 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.07399892 |
| 45 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.06300842 |
| 46 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.06175763 |
| 47 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.04907666 |
| 48 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.04008461 |
| 49 | RNA polymerase_Homo sapiens_hsa03020 | 1.03344457 |
| 50 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.02109983 |
| 51 | Circadian entrainment_Homo sapiens_hsa04713 | 1.01312156 |
| 52 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.01262077 |
| 53 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.99454930 |
| 54 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.97085144 |
| 55 | Proteasome_Homo sapiens_hsa03050 | 0.97022760 |
| 56 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.94060171 |
| 57 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.88039651 |
| 58 | ABC transporters_Homo sapiens_hsa02010 | 0.86099724 |
| 59 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.85010812 |
| 60 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.79261029 |
| 61 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.76516491 |
| 62 | Parkinsons disease_Homo sapiens_hsa05012 | 0.75769589 |
| 63 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.75336642 |
| 64 | Salivary secretion_Homo sapiens_hsa04970 | 0.73032568 |
| 65 | Mineral absorption_Homo sapiens_hsa04978 | 0.72964157 |
| 66 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.71514102 |
| 67 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.69117857 |
| 68 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.68923660 |
| 69 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.68100546 |
| 70 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.66562221 |
| 71 | Metabolic pathways_Homo sapiens_hsa01100 | 0.61479284 |
| 72 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.60345625 |
| 73 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.60312263 |
| 74 | Alzheimers disease_Homo sapiens_hsa05010 | 0.59741820 |
| 75 | Insulin secretion_Homo sapiens_hsa04911 | 0.59453506 |
| 76 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.59176070 |
| 77 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.58443916 |
| 78 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.55149084 |
| 79 | Purine metabolism_Homo sapiens_hsa00230 | 0.54794006 |
| 80 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.54352852 |
| 81 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.53979457 |
| 82 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.53669059 |
| 83 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.49911123 |
| 84 | Huntingtons disease_Homo sapiens_hsa05016 | 0.49713827 |
| 85 | Circadian rhythm_Homo sapiens_hsa04710 | 0.47903095 |
| 86 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.45977174 |
| 87 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.45539576 |
| 88 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.44961513 |
| 89 | Renin secretion_Homo sapiens_hsa04924 | 0.38702089 |
| 90 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.38439311 |
| 91 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.36041440 |
| 92 | Asthma_Homo sapiens_hsa05310 | 0.35858478 |
| 93 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.35521508 |
| 94 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.35304352 |
| 95 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.35040501 |
| 96 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.34527629 |
| 97 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.32382680 |
| 98 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.30564683 |
| 99 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.28018550 |
| 100 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.26740812 |

